Skip to main content
BioCardia, Inc. logo

BioCardia, Inc. — Investor Relations & Filings

Ticker · BCDA ISIN · US09060U5074 LEI · 5493003EDBXRQRW22O75 US Manufacturing
Filings indexed 1,023 across all filing types
Latest filing 2021-01-19 Director's Dealing
Country US United States of America
Listing US BCDA

About BioCardia, Inc.

https://www.biocardia.com/

BioCardia, Inc. is a clinical-stage regenerative medicine company that develops cellular and cell-derived therapeutics for cardiovascular and pulmonary diseases. The company's lead program is the CardiAMP® cell therapy system, an autologous therapy that uses a patient's own bone marrow cells to potentially stimulate the body's natural healing response in the heart. This therapy is primarily being evaluated for the treatment of ischemic heart failure. In addition to its autologous platform, BioCardia is also developing CardiALLO™, an allogeneic cell therapy platform using cells from qualified donors. The company's approach integrates biotherapeutic candidates with proprietary delivery systems for targeted administration.

Recent filings

Filing Released Lang Actions
FORM 3
Director's Dealing
2021-01-19 English
FORM 8-K
Board/Management Information Classification · 100% confidence The document is a Form 8-K filed with the SEC, dated January 5, 2021, reporting the resignation of a board member and the election of a new board member. The key section is Item 5.02, which specifically addresses the departure and election of directors. There is no financial data or report content, only an announcement of management changes. The document also includes a press release attached as an exhibit related to the board changes. According to the filing definitions, announcements of changes in the company's board of directors or senior management fall under Board/Management Information (MANG). The document length is under 5,000 characters and is a current report, not a full annual or quarterly report. Therefore, the correct classification is MANG with high confidence.
2021-01-11 English
FORM 4
Director's Dealing
2021-01-05 English
FORM 4
Director's Dealing
2021-01-05 English
FORM 4
Director's Dealing
2021-01-05 English
FORM 4
Director's Dealing
2021-01-05 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.